Background: The treatment of molar furcation involvement is unpredictable due to
(PRP) and platelet rich fibrin (PRF) support an endogenous regenerative therapy. [8] [9] [10] Platelet concentrates have evolved from the first generation, primitive PRP to the second generation PRF. The natural fibrin is a three dimensional matrix, enmeshed with platelets, cytokines, glycanic chains, and structural glycoproteins, which act as a suitable scaffold for breeding human periosteal cells in bone tissue engineering. 11 It also stimulates osteoblastic activity leading to regeneration of intrabony and mandibular grade II furcation defects. 12, 13 Besides the biologic mediators, various techniques have evolved to improve the quantity and quality of the bone being regenerated. Among these agents are bisphosphonates viz. Alendronate (ALN), chemical analogs of pyrophosphates, which have an affinity to bind to hydroxyapatite crystals and prevent their dissolution. 14 They inhibit osteoclastic bone resorption with osteostimulative properties and matrix formation. 15 Although it is widely used in the management of systemic metabolic bone disorders such as tumor-induced hypercalcemia, osteoporosis and Paget's disease, osteonecrosis of the jaw bone is found to be associated when delivered systemically. 16 However, therapeutic effects of the drug retain no cytotoxic or hypoxic effects at a concentration less than 10 −6 M. 17 Its systemic as well as topical application has been found to be highly effective in preventing bone resorption without affecting mineralization or bone quality. 18, 19 The reconstruction of periodontium can be evaluated clinically, radiographically, or by histologic procedures. However, the assessment of regeneration by clinical parameters is not a foolproof method. Besides, because surgical re-entry is invasive, intraoral periapical radiographs (IOPA) is arbitrary, computed tomography (CT) has a high cost-to-benefit ratio and histologic section has ethical constraints; cone beam computed tomography (CBCT) has been recommended as a fairer means of assessment of regeneration that mimics the bone morphology radiographically. 20 Previously, very few clinical studies have been performed to evaluate the efficacy of 1% ALN gel and PRF in combination or alone in the treatment of intrabony and grade II furcation defects but have not been evaluated by CBCT. Therefore, the aim of the present study was to evaluate and compare the efficacy of 1% ALN with PRF and PRF alone and the amount of bone fill obtained in the treatment of grade II furcation defects by CBCT.
MATERIALS AND METHODS

Patient selection
This randomized controled clinical and radiological trial was conducted on 20 patients (mean age 48.45 ± 3.52 years (range 38-56 years, 14 females and 6 males) affected with chronic periodontitis selected from those visiting the Department of Periodontics and Implantology, VSPM Dental College and Research Centre, Nagpur, India from January to December 2017. The study was approved from the Institutional Ethics Committee and was registered with the clinical trial registryIndia (CTRI/2017/11/010370).
Sample size estimation and power analysis
The sample size was calculated with reference to the study by Pajnigara et al. (2017) 7 where the data on randomized controled clinical trial for Grade II furcation defect regeneration was referred. Power analysis was performed. The data for quantity of patients and defects resulted in an effect size of 0.7. A sample size of 20 patients was needed to achieve the stringent effect with 90% power and 95% confidence level.
Sample collection
A special pro-forma with a detailed case history, clinical examination, radiographic evaluation, and periodontal indices of the patient was designed so as to have a systematic and methodological recording of observation and information. Patients gave written consent to participate.
Inclusion criteria
After evaluation of phase I therapy (etiotropic phase) that is, scaling and root planning (SRP), patients with probing pocket depth (PPD) ≥5 mm, clinical attachment level (CAL) ≥3 mm and at least one pair of bilateral buccal grade II furcation defects in either maxillary or mandibular molars with horizontal probing depth (HPD) > 2 mm were included in the study with no prior history of periodontal therapy or antibiotic therapy for 6 months.
Exclusion criteria
Patients with a history of known systemic diseases and blood disorders, allergies or drug usage, pregnant and lactating mothers, smokers, tobacco chewers, and patients with poor oral hygiene index (PI > 1.5) were excluded from the study. Any nonvital or carious teeth indicated for restorative therapy and mobility > grade II 21 were excluded from the study.
Presurgical therapy
Each patient was subjected to pre-surgical hygiene therapy consisting of a session of oral hygiene instructions, full mouth SRP using ultrasonic and hand instrumentation and occlusal adjustment as needed.
The selected sites were randomly assigned to PRF group and PRF+ALN group with a coin toss method performed by the operator who was the second examiner.
Clinical and radiographic measurements
Six weeks after the presurgical therapy the patients were re-evaluated for clinical data such as Plaque Index (PI), 22 Gingival Index (GI), 23 PPD, CAL using periodontal probe (UNC-15 Periodontal Probe, Hu-Freidy, Chicago, IL) and HPD using Naber's probe (2N Color-Coded Nabers Probe, Hu-Friedy, Chicago, IL) by examiner (SR). All surgeries were performed by operator (IW). Custom made occlusal acrylic stents were used to standardize the probe angulation and position recorded prior to the surgery. CBCT measurements were taken for each group that is, the PRF group and the PRF+ ALN group at baseline. Patients were masked for particular group and treatment allocation. The CBCT analysis included the measurement of bone defect height (DH) and defect width (DW), measured from the base of the defect to the fornix in the sagittal view and coronal view whereas the defect depth (DD) was measured in the bucco-lingual direction in axial view. These three parameters generated the total volume of the bone defect (DV). All the CBCT analyses were reported by the radiologist (AC) who was unaware of the groups.
Intraexaminer calibration
Intraexaminer calibration was achieved by the examination of 6 patients twice with a difference of 24 hours before starting the study. Measurements similar to 1 mm at baseline and 24 hours were included at calibration at the level of 95%.
ALN gel preparation
The 1% ALN gel was prepared as formulated by Reddy et al. 24 Sodium ALN was dissolved in a required amount of distilled water to achieve 1% sodium ALN concentration. Weighed quantity of polyacrylic acid (PAA) 934P (2% wt/wt) was taken and added to the distilled water. The mixture was stirred gradually and PAA was allowed to soak for 2 hours. Triethanolamine (1%) was added to neutralize the PAA solution and to form the gel. The pH was adjusted to 6.8. Finally, the required amounts of methylparaben (0.1%) and propylparaben (0.05%) were dissolved in ethanol and added to the gel.
PRF preparation
Before the surgical procedure, intravenous blood was collected by venipuncture of the antecubital vein in two 10 mL sterile test tubes and immediately placed in a centrifugation machine (R-4C, REMI, Mumbai, India) at 3000 rpm (approximately 400 × g) for 10 minutes. 25 This resulted in the composition of a structured fibrin clot in the middle of the tube, just between the red corpuscles at the bottom and acellular plasma [platelet-poor plasma (PPP)] at the top. PRF was easily separated from the red corpuscle base [preserving a small red blood cell (RBC) layer] using a sterile tweezers and scissors just after removal of PPP and then transferred on to a sterile compress. A stable fibrin membrane was obtained by squeezing serum out of the PRF clot.
After baseline examinations, the patients entered into the surgical phase of the regenerative therapy. An extra oral asepsis was maintained by povidone-iodine solution (Sceptre Medical India Private Limited, New Delhi, India) and 0.12% chlorhexidine digluconate (Dentrox, MonarkBiocare Private Limited Chandigarh, India) (CHLX) for intraoral rinsing. After adequate anesthesia (Lox 2% adrenaline (1:200000), Neon Laboratory Limited, Mumbai, India), a full thickness muco-periosteal flap was raised by placing an intra-sulcular incision extending at least one tooth mesial and distal to the treatment site preserving the interdental papilla wherever possible. All granulation tissue was removed from the bony wall of the defects. The root surfaces were thoroughly scaled and planed using hand instruments.
For the PRF group, PRF was placed over the defect after complete removal of granulation tissue. For the PRF+ALN group, 10 ml prepared 1% ALN gel (10 mg/ml) was injected into the furcation defect using a blunt cannula after defect debridement followed by similar treatment with PRF as stated earlier. The reflected flap was repositioned, secured with interrupted sutures (3-0 Ethicon Mersilk, Somerville, NJ) and periodontal dressing (GC coepak periodontal dressing, Alsip, IL) was placed (Figures 1 and 2 ).
Postoperative care
Patients were prescribed antibiotics (Moxikind CV 625 mg, Mankind Pharma, New Delhi, India) two times a day and analgesics (Ketorolac tromethamine 10 mg, Dr. Reddys Laboratories, Hyderabad, India) for seven day. Patients were instructed to use a CHLX mouth rinse (10 ml twice daily) and refrain from either chewing hard and sticky foods as well as forcefully brushing the treated sites until the sutures were removed 2 weeks after surgery. Surgical wounds were irrigated with 0.12% CHLX. Patient were instructed and motivated to perform tooth brushing having soft bristles and use of interdental aids until the next appointment at 3 and 6 months.
Postsurgical measurements
All clinical parameters with the same occlusal stents were reevaluated by the first examiner (SR) at 3 and 6 months (Figures 1 and 2 ) and by the radiologist (AC) for CBCT at 6 months (Figures 3 and 4 ).
Outcome measures (primary and secondary)
Radiographic bone fill from baseline to 6 months was the primary outcome whereas improvement in PI, GI, PPD and CAL 
Statistical analysis
The data was analyzed using the STATA version 13.0. The p-value was taken as significant when less than 0.05. PI, GI, PPD, CAL, HPD and DV were presented as mean and standard deviation, compared at different time point in each group by performing repeated measures of Analysis of Variance (ANOVA). Pairwise comparisons were made by Tukey's multiple comparison tests. Volume of defect was compared by Wilcoxon Signed Rank test for non-normalized data.
RESULTS
In this split mouth study design, a total of 40 furcation defects were treated with 26 maxillary and 14 mandibular molar furcation sites. All patients maintained good oral hygiene with uneventful wound healing throughout the course of the study. Mean PI scores of the study population were 3.13 ± 0.40, 2.47 ± 0.45, and 1.84 ± 0.36 and GI were 1.99 ± 0.39, 1.49 ± 0.31, and 1.17 ± 0.19 at baseline, 3 and 6 months respectively. There was a significant reduction in PI and GI at the end of 6 months in both the groups (p < 0.05). Table 1 shows the intragroup and intergroup comparison of PPD, CAL, and HPD at baseline, 3 and 6 months. The mean PPD,CAL, and HPD for PRF group was 5.30 ± 0.47 mm, 5.80 ± 0.70 mm, and 4.85 ± 0.81 mm whereas the PRF+ALN group was 5.70 ± 0.73 mm, 6.40 ± 1.10 mm and 4.95 ± 1.00 mm respectively. The mean reduction in PPD, CAL, and HPD at the end of 6 months for PRF group was 1.85 ± 0.59 mm, 1.9 ± 0.64 mm, and 1.7 ± 0.73 mm; and 2.85 ± 0.88 mm, 3.05 ± 0.98 mm and 2.3 ± 0.73 mm respectively for PRF+ ALN group. There was statistically significant improvement in clinical parameters for the PRF+ ALN group as compared to the PRF group (p < 0.05).
By comparing the radiographic mean DH, DW, DD and DV at baseline and 6 months, the reduction in DV was computed.
The baseline values of mean DH, DW, DD, DV in the PRF group were 2.78 ± 0.45 mm, 2.23 ± 0.46 mm, 2.51 ± 0.53, mm and 15.79 ± 5.85 mm 3 whereas in the PRF+ALN group they were 2.96 ± 0.47 mm, 2.36 ± 0.36 mm, 2.31 ± 0.35 mm, and 16.35 ± 5.37 mm 3 . At the end of 6 months the reduction in radiographic DH, DW, and DD was 0.70 ± 0.21 mm, 0.37 ± 0.42 mm, and 0.69 ± 0.31 mm for PRF group whereas for the PRF + ALN group it was 1.12 ± 0.41 mm, 0.79 ± 0.31 mm, and 0.83 ± 0.21 mm. DV for PRF and PRF+ ALN group was 8.65 ± 3.84 mm 3 and 11.98 ± 4.13 mm 3 at the end of 6 months (Table 2) . Although there was reduction in DV for both groups (p < 0.05), a statistically significant reduction was found in the PRF+ ALN group when compared to PRF group (p = 0.026). 
T A B L E 1 Comparison of changes in PPD, CAL, and HPD (in mm) at baseline, 3 months and 6 months in between study population
T A B L E 2 Comparison of changes in radiographic data
DISCUSSION
A better understanding of the host immune-inflammatory mediators and factors in the progression of the disease has developed pharmacologic and clinical strategies to modulate the rate of bone formation and resorption in periodontal treatment. Thus, the combined efficacy of 1% ALN gel with PRF on improvements in clinical parameters and subsequent bone fill was evaluated in the present study. The outcomes of the periodontal parameters of PI, GI, PPD, CAL and volumetric analysis of the bone defects by CBCT have helped us to derive significant conclusions. No substantial differences in any of the investigated parameters were observed at baseline between PRF group and PRF+ALN group indicating effective randomization.
All the patients showed good oral hygiene and clinically healthy gingiva throughout the duration of the study. This can be attributed to the constant reinforcement and motivation to maintain good oral hygiene. In a report of clinical trials comparing PRP and PRF presented by Raja et al., PRF was found to be cost effective, easily prepared and lacked biochemical handling of blood and cytotoxic properties as compared to PRP. 26 The suitability of PRF as a biologically active scaffold for proliferation and differentiation of osteoblasts and gingival fibroblasts has been illustrated in the literature. [27] [28] [29] [30] In a comparative analysis of PRF and Nova bone in class II furcation defects by Biswas et al., CAL gain of 3.7 ± 0.11 mm and 2.1 ± 0.12 mm was achieved respectively at the end of 6 months indicating that PRF was a better regenerative material than the synthetic alloplasts. 31 In our study, a significant variation for PPD and CAL between the PRF and PRF+ALN group at the end of 6 months was found. Although the resultant observations enabled the patient in better plaque control and oral hygiene maintenance, this gain in PPD and CAL were lesser to that observed in previous studies. 12, 19 Sharma et al. had found a reduction of 4.056 ± 0.416 mm in PPD and 2.333 ± 0.485 mm in RVCAL at the end of 9 months on application of PRF in grade II furcation defects. The higher observation in PPD and relative vertical clinical attachment level (RVCAL) reduction can be attributed to the longer time span (9 months) for evaluation. 12 Similarly, in a study by Pradeep et al., reduction in PPD and RVCAL were found to be 3.83 ± 0.70 mm and 3.23 ± 0.63 mm respectively, which was again higher than the present study. This difference could be attributed to different treatment modality of grade II furcation defects i.e. local delivery of ALN gel and not as an adjunct to OFD. 19 At 6 months, a significantly lesser mean HPD reduction was observed for PRF group as compared to the PRF+ ALN group. These results were similar to those reported by Kanoriya et al., who compared the potential of OFD alone, PRF+OFD, and PRF+ALN+ OFD in the treatment of mandibular molar degree II furcation defects and found a significant improvement in clinical parameters in both test groups at 9 month. The authors reported PPD and relative horizontal attachment level reduction of 4.4 ± 0.57 mm and 4.12 ± 0.6 mm respectively, which was the highest with the combination therapy (PRF + ALN+ OFD) signifying the accessory efficiency of integrated different approaches serving growth mediating factors for regeneration. 32 In the present study, possible reasons for better results in PRF + ALN group could be because of the additional influence ALN exhibits over the local tissues. PRF releases growth factors (PDGF-AB, VEGF, TGF-1, IGF, thrombospondin-1) and cytokines (IL-1,4,6) sustained for more than a week thereby stimulating neovascularization with proliferation of fibroblasts and may aid in the formation of a healthy granulation tissue for regeneration. [27] [28] [29] [30] ALN upregulates mRNA expression owing to the formation of BMP-2, collagen type I, osteocalcein and osteopontin by osteogenic differentiation. 33 Also, by inhibiting the activity of MMP-1, MMP-3, and MMP-8, ALN may influence the effect of inflammatory diseases. This inhibition of MMP activity at the bone surface might block the initiating step of the bone resorption process when delivered as an adjunct to surgical therapy. 34 Therefore, even though, the application of both PRF alone as well as PRF+ALN onto the furcation defects lead to significant improvements in clinical parameters, a better regenerative potential with PRF+ ALN could be confirmed radiographically.
To the authors knowledge no other previous studies have evaluated the amount of defect fill obtained with PRF or PRF+ALN by using CBCT. Hence, the results of the present study could not be correlated with any previous research. Nevertheless, previous studies on ALN with PRF have found significant radiographic defect fill % with the combination therapy (PRF with ALN) in grade II furcation defects and intrabony defects when evaluated using a conventional peri-apical radiograph at 9 months. 32, 35 As reported by Pajnigara et al., CBCT proves to be far superior in accurately diagnosing and evaluating the treatment results in furcation defects. 36 Walter et al. had also assessed the efficiency of CBCT to confirm the furcation involvement in maxillary molars and evaluated the volume of defect fill. 37 He had found that 84% of the CBCT data was accurate when compared intra-surgically, 14.7% of the sites were underestimated whereas only 1.3% of the sites were overestimated. Similar to previous reports, CBCT analysis in this study has enabled us to volumetrically assess the healing characteristics and regeneration with relatively less invasion. 38, 39 Further long-term, multicenter studies with biochemical assays and histologic evaluation for the regenerated tissues should be performed that would advocate and support the outcomes of the combination therapy.
CONCLUSION
The results of the present study show that 1% ALN+ PRF induced no clinical evidence of undesirable immune response and tissue reaction with more reduction in clinical and radiographic parameters as compared to PRF alone. Thus, the combination proved to be beneficial in achieving better periodontal regeneration. The evaluation of regeneration obtained by CBCT and clinical measurements has definitely increased our ability to determine the treatment outcome without a re-entry procedure.
